Companies / Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

NasdaqCanadaCIK 1702123OAKVILLE, Canada

Financials · FY2021 · CAD

RevenueC$78.8K
Net incomeC$-33.82M
Total debt—
CashC$21.42M
Diluted EPSC$-0.39
Shares outstanding100.3M

Ownership

100.3M shares outstanding
24.6%Institutions
Ownership
Institutions24.63%24,693,595
Public float75.37%75,563,414

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 0

View all →
Insider% of sharesShares
No insiders recorded yet.

Institutional holders 45

View all →
HolderValue% of shares
MMCAP International Inc. SPC$20.73M15.31%
Tejara Capital Ltd$4.89M5.12%
Two Sigma Investments, LP$721.2K0.53%
Integrity Alliance, LLC.$629.8K0.46%
AdvisorShares Investments LLC$570.4K0.60%
Bank of America Corp /De$350.2K0.37%
Morgan Stanley$328.5K0.34%
The Goldman Sachs Group, Inc.$313.3K0.33%
Renaissance Technologies LLC$310.2K0.23%
Susquehanna International Group, LLP$194.3K0.20%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
MMCAP International Inc. SPCPassive13G———
MMCAP International Inc. SPCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
———14161Y200—